Regardless of if you're in optimal health or managing a #lungcondition, there are many actions you can take to protect your lungs and uphold your general health and wellness. Learn more from the American Lung Association: https://bit.ly/3uUbdL1.
G1 Therapeutics, Inc.
Biotechnology Research
Research Triangle Park, NC 15,560 followers
Our mission is to discover, develop and deliver next generation cancer therapies.
About us
G1 Therapeutics, Inc. is a commercial-stage oncology company focused on the development and commercialization of next generation anti-cancer therapies. Led by a team with a deep understanding of the biology of cancer and extensive development and commercialization expertise, G1 is advancing its mission to improve the lives of those affected by cancer, including by commercializing the Company’s first commercial product, COSELA® (trilaciclib). G1 is also executing a development program, with a deep clinical pipeline evaluating targeted cancer therapies in a variety of solid tumors, including breast, lung, and bladder cancers. G1 Therapeutics is based in Research Triangle Park, N.C. For additional information, please visit www.g1therapeutics.com and follow us on Twitter @G1Therapeutics. View our social community guidelines here: https://www.g1therapeutics.com/social-guidelines
- Website
-
http://www.g1therapeutics.com
External link for G1 Therapeutics, Inc.
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Research Triangle Park, NC
- Type
- Public Company
- Founded
- 2008
- Specialties
- Cancer / Oncology, Drug Discovery and Development, and Biotechnology
Locations
-
Primary
Get directions
700 Park Offices Drive
Suite 200
Research Triangle Park, NC 27709, US
Employees at G1 Therapeutics, Inc.
Updates
-
What percent of people being treated for cancer with #chemotherapy need to alter their planned treatment course due to #myelosuppression (damage to the bone marrow caused by chemotherapy)? Drop your guess below and learn more about myelosuppression: https://bit.ly/3TfbelY.
This content isn’t available here
Access this content and more in the LinkedIn app
-
This #NationalCancerControlMonth let's celebrate the incredible courage of #cancer fighters and survivors and come together to support those impacted. Learn more about risk factors and prevention from the American Cancer Society: https://bit.ly/42U0NHT.
-
-
Join us in recognizing #WorldHealthDay! This year's theme is "My health, my right" and focuses on creating a healthier, more equitable world for everyone. Learn more: https://bit.ly/49u987F.
-
-
Women between the ages of 40-44 can start #breastcancer screening through yearly mammograms? Learn more about the importance of early detection and intervention from the American Cancer Society: https://bit.ly/48ywDv0.
-
-
During cell-specific treatments such as #chemotherapy, hematopoietic stem and progenitor cells (HSPCs) can undergo significant harm leading to a reduction in the #bloodcells, a condition often associated with #myelosuppression. Learn more here: https://bit.ly/3tIU5r9.
-
-
Some studies suggest that women may have a higher risk of developing #LungCancer, even when their smoking history is taken into account, than men. Check out the Lung Cancer Research Foundation for more facts about women and lung cancer: https://bit.ly/4aRw0iA.
-
-
#DYK: that about 15-20% of #breastcancers in the U.S. are #TripleNegative (TNBC)? While #TNBC may occur more often in certain populations, anyone can be diagnosed. Learn more from Susan G. Komen: https://bit.ly/4940PPt.
-
-
While doctors don't always know why #LungCancer occurs, certain risk factors are known to increase someone's chance of being diagnosed. Learn more about these risk factors from LUNGevity: https://bit.ly/41Opcy4.
-
-
We are dedicated to supporting patients in their battle against #cancer. Find out more about our mission and the work we do: https://bit.ly/3vucCbf.
-